ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 35 filers reported holding ESSA PHARMA INC in Q3 2023. The put-call ratio across all filers is 5.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $65,918 | -10.7% | 24,414 | -1.8% | 0.00% | – |
| Q1 2023 | $73,810 | -41.3% | 24,852 | -50.2% | 0.00% | – |
| Q4 2022 | $125,804 | +179.6% | 49,922 | +100.9% | 0.00% | – |
| Q3 2022 | $45,000 | -53.6% | 24,851 | -19.1% | 0.00% | – |
| Q2 2022 | $97,000 | -75.7% | 30,711 | -52.4% | 0.00% | – |
| Q1 2022 | $399,000 | -56.0% | 64,550 | +1.1% | 0.00% | – |
| Q4 2021 | $907,000 | +239.7% | 63,850 | +91.1% | 0.00% | – |
| Q3 2021 | $267,000 | – | 33,410 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 4,223,799 | $26,103,000 | 3.37% |
| MPM BioImpact LLC | 660,892 | $4,084,000 | 1.10% |
| BVF INC/IL | 3,695,629 | $22,839,000 | 0.91% |
| Omega Fund Management, LLC | 328,196 | $2,028,000 | 0.42% |
| Eventide Asset Management | 4,170,259 | $25,772,000 | 0.40% |
| Frazier Life Sciences Management, L.P. | 692,910 | $4,282,000 | 0.36% |
| Bellevue Group AG | 5,034,814 | $31,115,000 | 0.36% |
| RTW INVESTMENTS, LP | 2,637,192 | $16,298,000 | 0.34% |
| Avidity Partners Management LP | 2,460,000 | $15,203,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 410,923 | $2,540,000 | 0.25% |